ATE423322T1 - Proteomanalyse biologischer flüssigkeiten - Google Patents

Proteomanalyse biologischer flüssigkeiten

Info

Publication number
ATE423322T1
ATE423322T1 AT04758253T AT04758253T ATE423322T1 AT E423322 T1 ATE423322 T1 AT E423322T1 AT 04758253 T AT04758253 T AT 04758253T AT 04758253 T AT04758253 T AT 04758253T AT E423322 T1 ATE423322 T1 AT E423322T1
Authority
AT
Austria
Prior art keywords
fetal
biological fluids
proteom
analysis
identification
Prior art date
Application number
AT04758253T
Other languages
English (en)
Inventor
Ron Rosenfeld
Sri Nagalla
Mike Gravett
Original Assignee
Proteogenix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteogenix Inc filed Critical Proteogenix Inc
Application granted granted Critical
Publication of ATE423322T1 publication Critical patent/ATE423322T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Detergent Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT04758253T 2003-03-25 2004-03-23 Proteomanalyse biologischer flüssigkeiten ATE423322T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/400,005 US7191068B2 (en) 2003-03-25 2003-03-25 Proteomic analysis of biological fluids

Publications (1)

Publication Number Publication Date
ATE423322T1 true ATE423322T1 (de) 2009-03-15

Family

ID=33096805

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04758253T ATE423322T1 (de) 2003-03-25 2004-03-23 Proteomanalyse biologischer flüssigkeiten

Country Status (12)

Country Link
US (3) US7191068B2 (de)
EP (2) EP1618388B1 (de)
JP (2) JP2006524331A (de)
CN (1) CN1795387A (de)
AT (1) ATE423322T1 (de)
AU (2) AU2004225527B2 (de)
CA (1) CA2560972A1 (de)
DE (1) DE602004019511D1 (de)
DK (1) DK1618388T3 (de)
ES (1) ES2322593T3 (de)
MX (1) MXPA05010325A (de)
WO (1) WO2004088324A2 (de)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040241775A1 (en) * 2002-11-14 2004-12-02 The Govt. Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services Methods and kits for determining risk of pre-term delivery
US8068990B2 (en) * 2003-03-25 2011-11-29 Hologic, Inc. Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
GB0313828D0 (en) * 2003-06-16 2003-07-23 Owen Smith Brian D O Salivary urate for diagnosis of pre-eclampsia
CA2577587A1 (en) * 2003-08-21 2005-03-03 Mcgill University Method and apparatus for analyzing amniotic fluid
US20050233400A1 (en) * 2004-03-03 2005-10-20 Weiner Carl P Proteomic method for predicting success of rescue cerclage
WO2005093413A2 (en) * 2004-03-22 2005-10-06 Yale University Diagnosis and treatment of preeclampsia
WO2006076025A2 (en) * 2004-05-14 2006-07-20 Amaox, Inc. Immune cell biosensors and methods of using same
EP1789805B1 (de) 2004-07-14 2010-09-15 The Regents of The University of California Biomarker für den frühzeitigen nachweis von ovarialkarzinom
US9488655B2 (en) * 2004-07-14 2016-11-08 The Regents Of The University Of California Biomarkers for detection of early- and late-stage endometrial cancer
US9487575B2 (en) 2004-07-14 2016-11-08 The Regents Of The University Of California Compositions and methods for treatment of gynecologic cancers
US7670792B2 (en) * 2004-07-14 2010-03-02 The Regents Of The University Of California Biomarkers for early detection of ovarian cancer
CA2591926A1 (en) * 2004-09-20 2006-03-30 Proteogenix, Inc. Diagnosis of fetal aneuploidy
DE602005023216D1 (de) * 2004-12-15 2010-10-07 Beth Israel Hospital Nukleinsäuren und polypeptide zur diagnose und behandlung von schwangerschaftskomplikationen
CN101268368A (zh) 2005-01-28 2008-09-17 儿童医疗中心有限公司 上皮癌的诊断和预后方法
ES2398233T3 (es) * 2005-03-18 2013-03-14 The Chinese University Of Hong Kong Un método para la detección de aneuploidías cromosómicas
EP1869463A4 (de) 2005-04-15 2010-05-05 Becton Dickinson Co Sepsisdiagnose
US20070087387A1 (en) 2005-04-21 2007-04-19 Prasad Devarajan Method for the Early Detection of Renal Disease Using Proteomics
US20080318264A1 (en) * 2005-09-09 2008-12-25 University Of Iowa Research Foundation Biomarkers Associated With Age-Related Macular Degeneration
US7312079B1 (en) 2005-10-06 2007-12-25 Lexicon Pharmaceuticals, Inc. Variants of FAM3C
US20070190580A1 (en) * 2005-10-31 2007-08-16 Beckman Coulter, Inc. Immunoassay of Fragments of Insulin-Like Growth Factor Binding Proteins
US20070162992A1 (en) * 2006-01-09 2007-07-12 Mcgill University Metabolomic determination in assisted reproductive technology
CA2640614A1 (en) * 2006-01-27 2007-08-09 Eastern Virginia Medical School Proteomic fingerprinting of human ivf-derived embryos: identification of biomarkers of developmental potential
US7790463B2 (en) 2006-02-02 2010-09-07 Yale University Methods of determining whether a pregnant woman is at risk of developing preeclampsia
WO2007109293A2 (en) * 2006-03-21 2007-09-27 Yale University Early diagnosis of congenital abnormalities in the offspring of diabetic mothers
CA2659585A1 (en) * 2006-08-16 2008-02-21 National Research Council Of Canada Inhibition of angiogenesis, tumorigenesis and cathepsin activity using insulin-like growth factor binding protein
WO2008046160A1 (en) * 2006-10-20 2008-04-24 Newcastle Innovation Limited Assay for the detection of biomarkers associated with pregnancy related conditions
WO2008079407A1 (en) * 2006-12-26 2008-07-03 Brigham Young University Serum proteomics system and associated methods
WO2008112424A1 (en) * 2007-03-08 2008-09-18 Mayo Foundation For Medical Education And Research Assessing heart failure
CA2723322A1 (en) * 2007-05-05 2008-11-13 The University Of Western Ontario Methods for the detection of preeclampsia
GB0711327D0 (en) * 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
US9726670B2 (en) 2007-07-19 2017-08-08 Biomerieux Method for the assay of liver fatty acid binding protein, ACE and CA 19-9 for the in vitro diagnosis of colorectal cancer
FR2919065B1 (fr) 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'apolipoproteine ai pour le diagnostic in vitro du cancer colorectal
FR2919060B1 (fr) 2007-07-19 2012-11-30 Biomerieux Sa Procede de dosage de l'ezrine pour le diagnostic in vitro du cancer colorectal.
FR2919063B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal.
CA2694112A1 (en) * 2007-07-20 2009-01-29 The University Of Utah Research Foundation Identification and quantification of biomarkers for evaluating the risk of preterm birth
WO2009046447A1 (en) * 2007-10-06 2009-04-09 Katalin Polgar Fetal open lesion detection system
JP2011506971A (ja) * 2007-12-13 2011-03-03 スリーエム イノベイティブ プロパティズ カンパニー 創傷試料を解析する方法
WO2009097579A1 (en) * 2008-01-30 2009-08-06 Proteogenix, Inc. Gestational age dependent proteomic changes of human maternal serum for monitoring maternal and fetal health
US20100016173A1 (en) * 2008-01-30 2010-01-21 Proteogenix, Inc. Maternal serum biomarkers for detection of pre-eclampsia
WO2009123737A2 (en) 2008-04-03 2009-10-08 Becton, Dickinson And Company Advanced detection of sepsis
US8481273B2 (en) * 2008-06-20 2013-07-09 University Of Delaware Perlecan fragments as biomarkers of bone stromal lysis
WO2009158423A1 (en) * 2008-06-25 2009-12-30 University Of Utah Research Foundation Identifying and quantifying biomarkers associated with preeclampsia
FR2933773B1 (fr) 2008-07-10 2013-02-15 Biomerieux Sa Procede de dosage de la proteine disulfide isomerase pour le diagnostic in vitro du cancer colorectal
US8476008B2 (en) 2008-07-23 2013-07-02 Diabetomics, Llc Methods for detecting pre-diabetes and diabetes
WO2011053832A1 (en) * 2009-10-29 2011-05-05 The Trustees Of Columbia University In The City Of New York Use of urinary ngal to diagnose sepsis in very low birth weight infants
ES2677944T3 (es) 2009-11-25 2018-08-07 Hologic Inc. Detección de infección intraamniótica
US20130058931A1 (en) 2010-03-11 2013-03-07 University Of Louisville Research Foundation, Inc. Methods of predicting and decreasing the risk of pregnancy loss
WO2011149962A1 (en) 2010-05-24 2011-12-01 The Trustees Of Columbia University In The City Of New York Mutant ngal proteins and uses thereof
AU2011257192A1 (en) * 2010-05-28 2013-01-10 Mind-Nrg Sa Neuregulin isoforms, neuregulin polypeptides and uses thereof
GB201016161D0 (en) 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
US20120142559A1 (en) * 2010-12-06 2012-06-07 Pronota N.V. Biomarkers and parameters for hypertensive disorders of pregnancy
GB201102108D0 (en) * 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method
US20140162941A1 (en) * 2011-07-27 2014-06-12 Baylor College Of Medicine Process for preparing biological samples
CN104039810A (zh) 2011-08-29 2014-09-10 加利福尼亚大学董事会 使用高密度脂蛋白(hdl)相关分子治疗和预防促炎性病状
KR101142434B1 (ko) * 2011-09-08 2012-05-08 (주)오비메드 조기양막파수 산모에서 비침습적인 양수 내 염증 및 감염의 예측 또는 진단 방법
CN102426243B (zh) * 2011-11-17 2014-03-19 成都创宜生物科技有限公司 以补体因子d为检测指标的子痫前期检测试剂盒的制备方法
AU2013296240B2 (en) 2012-08-03 2018-05-17 Lfb Usa, Inc. The use of antithrombin in extracorporeal membrane oxygenation
WO2014066568A1 (en) 2012-10-24 2014-05-01 Winthrop-University Hospital Non-invasive biomarker to identify subjects at risk of preterm delivery
EP2925337B1 (de) 2012-11-21 2019-07-03 The Trustees of Columbia University in the City of New York Mutante ngal-proteine und verwendungen davon
JP2016507221A (ja) * 2012-12-20 2016-03-10 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 熱安定性dnaポリメラーゼの特徴づけ
GB201305317D0 (en) * 2013-03-22 2013-05-08 Iles Raymond K Prenatal screening for fetal abnormalities and disorders of pregnancy
WO2014210031A1 (en) 2013-06-25 2014-12-31 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Proteomic biomarkers of sepsis in elderly patients
FR3036188B1 (fr) 2015-05-12 2019-06-07 Biomerieux Prediction du risque de developper, pour des patients admis en service de reanimation, une infection disseminee
PL3311158T3 (pl) 2015-06-19 2023-11-27 Sera Prognostics, Inc. Pary biomarkerów do przewidywania przedwczesnego porodu
MA45272A (fr) 2015-06-27 2018-05-02 Stimlabs Llc Produits issus de liquide amniotique et procédés d'utilisation
CN105372414B (zh) * 2015-10-09 2017-12-22 成都大熊猫繁育研究基地 大熊猫乳汁中关键因子的分析方法
CN110366597B (zh) * 2016-12-20 2024-03-29 善威生物私人有限公司 用蛋白酶抑制剂进行血液图谱分析
CA3073192A1 (en) 2017-08-18 2019-02-21 Sera Prognostics, Inc Pregnancy clock proteins for predicting due date and time to birth
JP2020533595A (ja) 2017-09-13 2020-11-19 プロジェニティ, インコーポレイテッド 子癇前症バイオマーカならびに関連するシステムおよび方法
US20190224277A1 (en) * 2018-01-22 2019-07-25 CyPhi LLC Bio-mimetic formulation
EP4070113A4 (de) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. Beurteilung von präeklampsie unter verwendung von tests für freien und dissoziierten plazentalen wachstumsfaktor
CN113092771A (zh) * 2019-12-23 2021-07-09 首都医科大学附属北京世纪坛医院 尿液α-1B-糖蛋白及其多肽片段在过敏性疾病中的应用
CN113092773A (zh) * 2019-12-23 2021-07-09 首都医科大学附属北京世纪坛医院 尿液α-胰蛋白酶抑制剂重链H4及其多肽片段在过敏性疾病中的应用
CN111951969A (zh) * 2020-08-05 2020-11-17 中翰盛泰生物技术股份有限公司 Hbp在高危妊娠预测中的应用

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871937A (en) * 1985-04-30 1999-02-16 The Scripps Research Institute Acute phase protein modulating endotoxic activity of lipopolysaccharides, assay methods and polypeptides
US5516702A (en) * 1991-11-06 1996-05-14 Adeza Biomedical Corporation Screening method for identifying women at increased risk for imminent delivery
US6036955A (en) * 1992-03-05 2000-03-14 The Scripps Research Institute Kits and methods for the specific coagulation of vasculature
US5484705A (en) * 1994-01-24 1996-01-16 Xoma Corporation Method for quantifying lipopolysaccharide binding protein
US5891618A (en) * 1994-01-24 1999-04-06 Xoma Corporation Method for quantifying LBP in body fluids
US5932536A (en) * 1994-06-14 1999-08-03 The Rockefeller University Compositions for neutralization of lipopolysaccharides
US20020164818A1 (en) * 1995-05-23 2002-11-07 Gruber Karl F. Mass spectrometric immunoassay analysis of specific proteins and variants present in various biological fluids
WO1996037777A1 (en) * 1995-05-23 1996-11-28 Nelson Randall W Mass spectrometric immunoassay
CA2321223A1 (en) * 1998-02-25 1999-09-02 National University Of Ireland, Cork Hla linked pre-eclampsia and miscarriage susceptibility gene
US6324479B1 (en) * 1998-05-08 2001-11-27 Rosetta Impharmatics, Inc. Methods of determining protein activity levels using gene expression profiles
US6406921B1 (en) * 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
CA2356867A1 (en) * 1998-12-28 2000-07-06 Kabushiki Kaisya Advance System for identifying microorganism
WO2000052471A1 (en) * 1999-03-01 2000-09-08 The Board Of Trustees Of The Leland Stanford Junior University Rapid assay for chorioamnionitis
WO2000060354A1 (en) * 1999-04-07 2000-10-12 Unilever Plc Lipopolysaccharide immunoassay and test device
US6613327B1 (en) * 1999-07-28 2003-09-02 Genetics Institute, Inc. Methods of preventing immune-mediated abortion by inhibiting a CD28-mediated costimulatory signal
US6653151B2 (en) * 1999-07-30 2003-11-25 Large Scale Proteomics Corporation Dry deposition of materials for microarrays using matrix displacement
US6703202B2 (en) * 1999-11-30 2004-03-09 Oxo Chemie Ag Evaluating and predicting clinical outcomes by gene expression analysis
EP2299274A1 (de) * 2002-03-07 2011-03-23 Medical Research Council SCD Fingerabdrücke
CN1395103A (zh) * 2002-07-31 2003-02-05 中华人民共和国北京出入境检验检疫局 疯牛病病原检测压电生物芯片及其制备方法
US20040241775A1 (en) * 2002-11-14 2004-12-02 The Govt. Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services Methods and kits for determining risk of pre-term delivery
AU2003290773A1 (en) * 2003-02-05 2004-09-06 Ciphergen Biosystems, Inc. Non-invasive assessment of intra-amniotic environment
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
WO2005017192A2 (en) * 2003-08-14 2005-02-24 The General Hospital Corporation Screening for gestational disorders
ES2556164T3 (es) * 2003-09-23 2016-01-13 The General Hospital Corporation Cribado de la preeclampsia
US20060063162A1 (en) * 2004-09-23 2006-03-23 Deng David X Biological marker for inflammation
WO2006036182A2 (en) * 2004-09-28 2006-04-06 Singulex, Inc. System and method for spectroscopic analysis of single particles
GB0426982D0 (en) * 2004-12-09 2005-01-12 Secr Defence Early detection of sepsis
EP1869463A4 (de) * 2005-04-15 2010-05-05 Becton Dickinson Co Sepsisdiagnose
US20070037224A1 (en) * 2005-08-11 2007-02-15 Hamer Peter J Quantitative assays for PDGFR-beta in body fluids
AU2006299417A1 (en) * 2005-10-03 2007-04-12 Biosite Incorporated Methods and compositions for diagnosis and/or prognosis in Systemic Inflammatory Response Syndromes
WO2007047041A2 (en) * 2005-10-14 2007-04-26 Hyperion Biotechnology, Inc. Methods and compositions for biomarkers associated with change in physical performance
US7790463B2 (en) * 2006-02-02 2010-09-07 Yale University Methods of determining whether a pregnant woman is at risk of developing preeclampsia
WO2007092427A2 (en) * 2006-02-06 2007-08-16 Palingen, Inc. Treatment of endotoxemia using endotoxin neutralizing agents
KR100981202B1 (ko) * 2006-05-31 2010-09-10 한화케미칼 주식회사 Vcam-1 특이적 단일클론항체
US20080199426A1 (en) * 2007-01-11 2008-08-21 Sukhatme Vikas P Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders

Also Published As

Publication number Publication date
EP1618388A2 (de) 2006-01-25
US20090055099A1 (en) 2009-02-26
ES2322593T3 (es) 2009-06-23
EP2088433A1 (de) 2009-08-12
AU2004225527B2 (en) 2009-10-29
MXPA05010325A (es) 2006-03-17
JP5011410B2 (ja) 2012-08-29
US7191068B2 (en) 2007-03-13
US20080299594A1 (en) 2008-12-04
US20040197930A1 (en) 2004-10-07
CA2560972A1 (en) 2004-10-14
DK1618388T3 (da) 2009-05-18
AU2010200352A1 (en) 2010-02-18
WO2004088324A3 (en) 2005-06-02
EP1618388B1 (de) 2009-02-18
JP2006524331A (ja) 2006-10-26
JP2010122238A (ja) 2010-06-03
WO2004088324A2 (en) 2004-10-14
CN1795387A (zh) 2006-06-28
DE602004019511D1 (de) 2009-04-02
AU2004225527A1 (en) 2004-10-14

Similar Documents

Publication Publication Date Title
ATE423322T1 (de) Proteomanalyse biologischer flüssigkeiten
DE602004031818D1 (de) Halbkugelförmiges Ventil für eine medizinische Vorrichtung
DE602004019614D1 (de) Medizinische Vorrichtung für Endoskope
DE602004031846D1 (de) Verbesserungen bei blutentnahmegeräten
ATE424560T1 (de) Marker für neuromyelitis optica
ATE306221T1 (de) Vorrichtung für die osteosynthese
DE602004022041D1 (de) Gerät und methoden für das desinfizieren von oberflächen
DE60214087D1 (de) Vorrichtung zur Entnahme biologischer Flüssigkeiten und Analytenmessung
HK1129926A1 (en) Proteomic analysis of cervical-vaginal fluids for detecting intra-uterine infection or determining pre-term delivery risk in a pregnant female
DE60237172D1 (de) Diagnostisches System für Verdichter
DE602004006152D1 (de) Fixierung für medizinische leitungen
DE60239398D1 (de) Hydrophile diagnosevorrichtungen zur verwendung beim testen biologischer flüssigkeiten
ATE336506T1 (de) Verwendung löslicher cytokeratin-1-fragmente in diagnostik
DE502004003429D1 (de) Medizinisches instrument mit endoskop
DE602004028071D1 (de) Halter - Anordnung für eine medizinische Naddle
DE502004005673D1 (de) Medizinisches Instrument
ATE402726T1 (de) Gerät für die manuelle oder automatische injektion von injektionspräparaten
ITRN20030024A1 (it) Dispositivo per il prelievo di campioni biologici e/o chimici.
DE60234250D1 (de) Vorrichtung zur Zell- bzw. Gewebezüchtung
DK1406927T3 (da) Glycopeptider, fremstilling og anvendelse deraf til diagnosticering eller terapeutisk behandling af dissemineret sklerose
DE60327121D1 (de) Leseverfahren, und Responder und Interrogator
ITRM20040122A1 (it) Complesso di valvola per compressori alternativi.
DE602004003096D1 (de) Pedometer zur Verwendung bei schwangeren Frauen
DE50205369D1 (de) Rückschlagventil für eine pumpe
DE60203256D1 (de) System für eine implantierbare medizinische Vorrichtung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1618388

Country of ref document: EP